Dmd050005 1584..1591

نویسندگان

  • Kazuaki Taguchi
  • Hayato Ujihira
  • Shigeru Ogaki
  • Hiroshi Watanabe
  • Atsushi Fujiyama
  • Mami Doi
  • Yosuke Okamura
  • Shinji Takeoka
  • Yasuo Ikeda
  • Makoto Handa
  • Masaki Otagiri
  • Toru Maruyama
چکیده

Fibrinogen g-chain (dodecapeptide HHLGGAKQAGDV, H12)–coated, ADP-encapsulated liposomes [H12-(ADP)-liposomes] were developed as a synthetic platelet alternative that specifically accumulates at bleeding sites as the result of interactions with activated platelets via glycoprotein IIb/IIIa and augments platelet aggregation by releasing ADP. The aim of this study is to characterize the pharmacokinetic properties of H12-(ADP)-liposomes and structural components in rats, and to predict the blood retention of H12(ADP)-liposomes in humans. With use of H12-(ADP)-liposomes in which the encapsulated ADP and liposomal membrane cholesterol were radiolabeled with C and H, respectively, it was found that the time courses for the plasma concentration curves of C and H radioactivity showed that the H12-(ADP)-liposomes remained intact in the blood circulation for up to 24 hours after injection, and were mainly distributed to the liver and spleen. However, the C and H radioactivity of H12-(ADP)-liposomes disappeared from organs within 7 days after injection. The encapsulated ADP was metabolized to allantoin, which is the final metabolite of ADP in rodents, and was mainly eliminated in the urine, whereas the cholesterol was mainly eliminated in feces. In addition, the half-life of the H12(ADP)-liposomes in humans was predicted to be approximately 96 hours from pharmacokinetic data obtained for mice, rats, and rabbits using an allometric equation. These results suggest that the H12-(ADP)-liposome has potential with proper pharmacokinetic and acceptable biodegradable properties as a synthetic plate-

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Vascular tumors

7. Gerald WL, Ladanyi M, de Álava E at al. Clinical, Pathologic and molecular spectrum of tumors associated with t(11;22)(p13;q12): Desmoplastic small round cell tumorand its variants.J Olin Oncol 1998; 16: 3028-3036. 8. Antoneacu CR, Gerald WL, Magid MS at al. Molecular variants of the EWSWT1 gene fusion in desmoplastic small round cell tumor. Diagn Mol Pathol 1998; 7: 24-28. 9. de Álava E, La...

متن کامل

The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications

Previously, we cloned and sequenced the three novel MHC class I genes expressed by the C3H UV fibrosarcoma, 1591. We have extended the analysis of the polymorphic nature of these genes relative to the C3H strain. Scattered nucleotide differences among the tumor genes as compared with the C3H H-2 and Qa sequences make it highly unlikely that the novel tumor genes were generated by recombination ...

متن کامل

On total vertex irregularity strength of graphs

Martin Bača et al. [2] introduced the problem of determining the total vertex irregularity strengths of graphs. In this paper we discuss how the addition of new edge affect the total vertex irregularity strength.

متن کامل

Paediatric respiratory training in Europe: syllabus and centres.

The European training syllabus in paediatric respiratory medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . 1588 Introduction . . . . . . . . . . . . . . . . . . . . . . . 1588 Aims of training. . . . . . . . . . . . . . . . . . . . . 1588 Training programme. . . . . . . . . . . . . . . . . . 1589 The trainee . . . . . . . . . . . . . . . . . . . . . . . . 1591 Training centres/tuto...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013